CD4 and cancer: These observations highlight the importance of considering naïve CD4+ T cell states during inflammatory diseases such as autoimmunity, infection and cancer, as aberrant naïve CD4+ T cells may contribute to increased disease burden, or exhibit varying responses to therapies due to the experience of inflammation.